Molecular modeling for the interaction between proteasome beta 5 subunit and organotin compounds

Science China Chemistry

Volumn 53, Issue 11, 2010, Pages 2387-2393

  Shi, Guoqing ^a   Sun, Qing ^a   Yang, Huanjie ^b   Dou, Qingping ^b   Deng, Qianmin ^a   Wang, Haiou ^a   Zhong, Guangrong ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY BEIJING   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chymotrypsin like activity; docking; organotin; proteasome

Indexed keywords

CHYMOTRYPSIN-LIKE ACTIVITY; COMPUTATIONAL DOCKINGS; COORDINATE BONDS; CYTOTOXIC; IN-SILICO; INHIBITION CONSTANTS; INTERACTION MODES; ORGANOMETALLIC COMPOUNDS; ORGANOTIN COMPOUND; ORGANOTINS; PREDICTIVE MODELS; PROTEASOME INHIBITORS; PROTEASOMES; TRIBUTYLTIN; TRIPHENYLTIN;

CELL DEATH; DOCKING; TIN; TIN COMPOUNDS;

ORGANOMETALLICS;

EID: 78649921819     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-010-4034-8     Document Type: Article

References (20)

1. J.B. Almond G.M. Cohen 2002 The proteasome: A novel target for cancer chemotherapy Leukemia 16 433 443 1:CAS:528:DC%2BD38XjvFGnur8%3D 10.1038/sj.leu.2402417
2. X. Li D. Yang L. Li C. Peng S. Chen W. Le 2007 Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures Neurochem Int 50 959 965 1:CAS:528: DC%2BD2sXmvVKmsLg%3D 10.1016/j.neuint.2007.04.014
3. J. Adams V.J. Palombella E.A. Sausville J. Johnson A. Destree D.D. Lazarus J. Maas C.S. Pien S. Prakash P.J. Elliott 1999 Proteasome inhibitors: A novel class of potent and effective antitumor agents Cancer Res 59 2615 2622 1:CAS:528:DyaK1MXjs1ymsbY%3D
4. R.C. Kane A.T. Farrell R. Sridhara R. Pazdur 2006 United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy Clin Cancer Res 12 2955 2960 1:CAS:528:DC%2BD28Xks1Cisb8%3D 10.1158/1078-0432.CCR-06-0170
5. M. Groll M. Bochtler H. Brandstetter T. Clausen R. Huber 2005 Molecular machines for protein degradation ChemBioChem 6 222 256 1:CAS:528: DC%2BD2MXhsVKhtbs%3D 10.1002/cbic.200400313
6. Q.P. Dou S. Nam 2000 Pharmacological proteasome inhibitors and their therapeutic potential Exp Opin Ther Patents 10 1263 1272 1:CAS:528: DC%2BD3cXlvFWqu7g%3D 10.1517/13543776.10.8.1263
7. M. Groll L. Ditzel J. Lowe D. Stock M. Bochtler H.D. Bartunik R. Huber 1997 Structure of 20S proteasome from yeast at 2.4 Å resolution Nature 386 463 471 1:CAS:528:DyaK2sXisVSqsr0%3D 10.1038/386463a0
8. J. Kohno Y. Koguchi M. Nishio K. Nakao M. Kuroda R. Shimizu T. Ohnuki S. Komatsubara 2000 Structures of TMC-95A-D: Novel proteasome inhibitors from Apiospora montagnei sacc TC 1093. J Org Chem 65 990 995 1:CAS:528: DC%2BD3cXotlOnuw%3D%3D 10.1021/jo991375+
9. K.G. Daniel D. Chen S. Orlu Q.C. Cui F.R. Miller Q.P. Dou 2005 Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Res 7 897 908 10.1186/bcr1322
10. V. Milacic D. Chen L. Ronconi K.R. Landis-Piwowar D. Fregona Q.P. Dou 2006 A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts Cancer Res 66 10478 10486 1:CAS:528:DC%2BD28XhtFGjsrbO 10.1158/0008-5472.CAN-06-3017
11. D. Chen M. Frezza R. Shakya Q.C. Cui V. Milacic C.N. Verani Q.P. Dou 2007 Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects Cancer Res 67 9258 9265 1:CAS:528: DC%2BD2sXhtFSnur3M 10.1158/0008-5472.CAN-07-1813
12. G.Q. Shi D. Chen G.S. Zhai M.S. Chen Q.C. Cui Q.F. Zhou B. He Q.P. Dou G.B. Jiang 2009 The proteasome is a molecular target of environmental toxic organotins Environ Health Perspect 117 379 386 1:CAS:528:DC%2BD1MXjvVWlsrs%3D
13. X. Chen G.Q. Shi G.R. Zhong J. Chen S. Lin Q. Sun 2010 Triphenyltin inhibition of the proteasome activity and its influence on substrate protein levels in nerve cells Chin Sci Bull 55 1 22 26 1:CAS:528:DC%2BC3cXhtVSlu7g%3D 10.1007/s11434-009-0678-1
14. C.G. Arnold A. Weidenhaupt M.M. David S.R. Müller S.B. Haderlein R.P. Schwarzenbach 1997 Aqueous speciation and 1-octanol-water partitioning of tributyl- and triphenyltin: Effect of pH and ion composition Environ Sci Technol 31 2596 2602 1:CAS:528:DyaK2sXks1Gjsrk%3D 10.1021/es970009+
15. J.S. White J.M. Tobin 2004 Role of speciation in organotin toxicity to the yeast Candida maltosa Environ Sci Technol 38 3877 3884 1:CAS:528: DC%2BD2cXksFyrtbg%3D 10.1021/es030099k
16. M.M. Mohamed M.M. Shoukry 2001 Interaction of diphenyltin(IV) dichloride with some selected bioligands Chem Pharm Bull 49 253 257 1:CAS:528: DC%2BD3MXhs1Ohs7k%3D 10.1248/cpb.49.253
17. G.M. Morris D.S. Goodsell R.S. Halliday R. Huey W.E. Hart R.K. Belew A.J. Olson 1998 Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J Comput Chem 19 1639 1662 1:CAS:528:DyaK1cXntFemur4%3D 10.1002/(SICI)1096-987X(19981115)19:14<1639:: AID-JCC10>3.0.CO;2-B
18. R. Huey G.M. Morris A.J. Olson D.S. Goodsell 2007 A semiempirical free energy force field with charge-based desolvation J Comput Chem 28 6 1145 1152 1:CAS:528:DC%2BD2sXjsVSms78%3D 10.1002/jcc.20634
19. K. Burda J. Lekki J. Cieslak J. Kruk M. Lekka S. Dubiel J. Stanek Z. Stachura 2002 Molecular mechanism of haemolysis induced by triphenyltin chloride Appl Organometal Chem 16 148 154 1:CAS:528:DC%2BD38XhsFeqsLc%3D 10.1002/aoc.272
20. M. Karelson V.S. Lobanov 1996 Quantum-chemical descriptors in QSAR/ QSPR studies Chem Rev 96 1027 1043 1:CAS:528:DyaK28Xitl2rtbY%3D 10.1021/cr950202r